PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas Ca

Clinical trial NCT00467116 · COMPLETED

Trial details

NCT number: NCT00467116
Sponsor: Vanderbilt-Ingram Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Pancreatic Cancer

Start date: 2005-10-01
Primary completion: 2007-08-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.